FDA WARNING_LETTER - Eniva USA, Inc. - January 13, 2025

FDA WARNING_LETTER for Eniva USA, Inc. on January 13, 2025. Product: Dietary Supplements. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA WARNING_LETTER for Eniva USA, Inc. on January 13, 2025. Product: Dietary Supplements. Access full analysis and detailed observations.

Violation Codes

21 CFR 111.70(e)

21 CFR 111

21 CFR 111.140(b)(3)

FD&C Act 402(g)(1)

21 U.S.C. 342(g)(1)

21 CFR 114.83

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Eniva USA, Inc.

Inspection Date

January 13, 2025

Product Type

Dietary Supplements

Office

Office of Compliance and Enforcement

People

ID: a2e56aaf-a4ae-4790-b069-4e36ccf20257

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox